Table 4.
Authors | CIT, min | Transplants, n | PNF, n | DBI, n | Composite endpoint |
---|---|---|---|---|---|
Dubbeld et al.22 | 456 | 55 | 1 | 13 | 25% |
Detry et al.23 | 451 | 58 | 2 | 7 | 15% |
Grewal et al.16 | 378 | 108 | 4 | 9 | 12% |
Pine et al.14 | 397 | 39 | 2 | 8 | 26% |
de Vera et al.13 | 657 | 141 | 17 | 24 | 29% |
Detry et al.15 | 295 | 13 | 0 | 0 | 0% |
Chan et al.12 | 437 | 52 | 0 | 7 | 14% |
Maheshwari et al.24 | 522 | 20 | 1 | 10 | 55% |
Skaro et al.25 | 330 | 32 | 1 | 12 | 41% |
Present study (BIDMC) data | 385 | 22 | 2 | 3 | 23% |
CIT, cold ischaemic time; PNF, primary non-function; DBI, diffuse biliary ischaemia; BIDMC, Beth Israel Deaconess Medical Center